Fibroblast growth factor receptors
(Redirected from Erdafitinib)
Jump to navigation
Jump to search
Fibroblast growth factor receptor, abbreviated FGFR, a molecule that transmit growth signals for fibroblasts. FGFR2 and FGFR3 redirect here.
An anti-FGFR therapy exists (erdafitinib).[1][2]
Anti-FGFR therapy
It is used in:
- Urothelial carcinoma.[2]
- Hepatobiliary cancers.[citation needed]
See also
References
- ↑ "Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review". J Cancer Res Clin Oncol 149 (8): 4915–4923. July 2023. doi:10.1007/s00432-022-04428-w. PMID 36307559.
- ↑ 2.0 2.1 "Fibroblast growth factor receptor (FGFR) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder". J Clin Pathol 74 (8): 491–495. August 2021. doi:10.1136/jclinpath-2020-207115. PMID 33731335.